Cited by 120Redox biology and oxidative stressCancer, Hypoxia, and MetabolismCancer and biochemical research

The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy

Policastro, Lucia Laura, Ibañez, Irene Laura, Notcovich, Cintia, Duran, Hebe Alicia, Podhajcer, Osvaldo Luis·2013·Antioxidants & Redox Signaling

Abstract

The tumor microenvironment is a complex system that involves the interaction between malignant and neighbor stromal cells embedded in a mesh of extracellular matrix (ECM) components. Stromal cells (fibroblasts, endothelial, and inflammatory cells) are co-opted at different stages to help malignant cells invade the surrounding ECM and disseminate. Malignant cells have developed adaptive mechanisms to survive under the extreme conditions of the tumor microenvironment such as restricted oxygen supply (hypoxia), nutrient deprivation, and a prooxidant state among others. These conditions could be eventually used to target drugs that will be activated specifically in this microenvironment. Preclinical studies have shown that modulating cellular/tissue redox state by different gene therapy (GT) approaches was able to control tumor growth. In this review, we describe the most relevant features of the tumor microenvironment, addressing reactive oxygen species-generating sources that promote a prooxidative microenvironment inside the tumor mass. We describe different GT approaches that promote either a decreased or exacerbated prooxidative microenvironment, and those that make use of the differential levels of ROS between cancer and normal cells to achieve tumor growth inhibition. Antioxid. Redox Signal. 19, 854–895. I. The Tumor Microenvironment A. Tumor microenvironment components 1. Malignant cells 2. Tumor-associated stromal cells a. Fibroblasts b. Tumor vasculature-associated cells c. Inflammatory cells 3. Extracellular matrix B. Tumor microenvironmental characteristics 1. Hypoxia a. General characteristics b. Molecular control of hypoxia 2. Tumor angiogenesis a. General characteristics b. Molecular control 3. Tumor metabolism a. General characteristics b. Molecular control 4. Tumor acidosis a. General characteristics b. Molecular control II. Redox Characterization of the Tumor Microenvironment A. ROS and cell sources B. Control of cellular redox homeostasis: the antioxidant system C. Altered ROS production in cancer cells 1. ROS production due to genetic alterations 2. mtROS produced by malignant cells 3. Deregulation of antioxidant mechanisms in cancer cells 4. ROS generated by the aberrant activity of malignant cells a. Cancer cell metabolism b. Cancer cell survival and proliferation c. Metastatic dissemination d. Cancer cell death 5. CSCs and redox consideration D. ROS generated by the tumor microenvironment 1. ROS generated by CAFs 2. ROS generated by inflammatory cells 3. ROS generated by ECs and the angiogenic process 4. ROS generated by the hypoxic microenvironment E. In vivo evidence of ROS generation in tumors III. ROS and Cancer Gene Therapeutics A. Introduction 1. Threshold ROS concept for cancer therapy 2. An overview of ROS-based cancer gene therapeutics B. GT strategies to modulate extra- or intracellular ROS levels 1. Decreasing ROS extra- or intracellular levels by GT strategies a. Overexpression of the antioxidant enzyme system in cancer cells b. Overexpression of the antioxidant enzyme system in the tumor stroma c. Knocking down NOXs d. Knocking down other ROS cell sources 2. Increasing intracellular levels of ROS by GT strategies in cancer cells a. Knocking down the antioxidant enzyme system (1) Superoxide dismutases (2) Peroxiredoxins (3) Glutathione peroxidases (4) The Trx system b. Overexpression of the antioxidant enzyme SOD c. Knocking down additional redox-associated cellular genes C. ROS-response elements to drive cancer gene therapeutics IV. Concluding Remarks and Future Perspectives

Integrity signals

Registry

Crossref · 10.1089/ars.2011.4367

Cites

352 of 352 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Since the tumour microenvironment is oxidative, high ascorbate levels would continuously and efficiently produce DHA.

    “Because the tumour microenvironment is known to be oxidative54,55, adding high concentrations of ascorbate would efficiently and continuously generate DHA from ascorbate.”

    From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [55]

Cites

3 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Policastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L.
Affiliations
  • Department of Micro and Nanotechnology, National Atomic Energy Commission, Buenos Aires, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
  • Comisión Nacional de Energía Atómica (AR)
Corresponding author
Podhajcer, Osvaldo Luis
Venue
Antioxidants & Redox Signaling
Published
2013-09-10
Volume
19
Issue
8
Pages
854-895
ISSN
  • 1523-0864 (ISSN-L)
  • 1557-7716
OpenAlex
W2005154655
Cited by
120
References
352
Citations by year
2026: 6 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 14 · 2021: 9 · 2020: 7 · 2019: 11 · 2018: 14 · 2017: 7 · 2016: 10 · 2015: 4 · 2014: 7 · 2013: 6 · 2012: 1
FWCI
0.53
Type
journal article
Language
en
Open access
closed
Locations
  • Antioxidants and Redox Signaling (publishedVersion)
  • PubMed (publishedVersion)
Funders
Agencia Nacional de Promoción Científica y Tecnológica
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
Keywords
tumor microenvironment, reactive oxygen species, redox state, gene therapy, hypoxia, extracellular matrix, cancer-associated fibroblasts, tumor angiogenesis, cancer metabolism, tumor acidosis, mitochondrial reactive oxygen species, antioxidant defense, cancer stem cells, oxidative stress, tumor stromal cells, metastasis, tumor growth inhibition
MeSH terms
Animals, Antioxidants, Humans, Neoplasms, Oxidation-Reduction, Oxidoreductases, Genetic Therapy, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Oxidative Stress, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review